Bill Search

  • Introduced
    Mar 11, 2025
  • Passed Senate
    Apr 30, 2025
  • Passed House
    May 13, 2025
  • Signed into Law
SB 2308
Texas Senate Bill
Did you know we offer free bill tracking in Congress and 50 states, and a great mobile app? Sign up here
Relating to the establishment of a consortium to conduct United States Food and Drug Administration's drug development clinical trials with ibogaine to secure the administration's approval of the medication's use for treatment of opioid use disorder, co-occurring substance use disorder, and any other neurological or mental health conditions for which ibogaine demonstrates efficacy and to the administration of that treatment.
Last Action See all actions
House • Jun 02, 2025: Signed in the House
Latest Bill Text See all bill texts

Summary/Bill Text

Comments on SB 2308

Tweets

Whip Lists

Sponsors
Votes
Actions
  • Jun 02, 2025 | House
    • Signed in the House
  • Jun 02, 2025 | Senate
    • Reported enrolled
  • Jun 01, 2025 | Senate
    • House adopts conf. comm. report-reported
  • Jun 01, 2025 | House
    • House adopts resolution to go outside bounds HR 1495
    • House adopts conference committee report
    • Record vote RV#4133
  • May 31, 2025 | House
    • Senate adopts conf. comm. report-reported
  • May 31, 2025 | Senate
    • Senate adopts resolution to go outside bounds SR 703
    • Senate adopts conference committee report
    • Record vote
  • May 30, 2025 | House
    • Conf. Comm. Report distributed
  • May 30, 2025 | Senate
    • Conference committee report filed
  • May 21, 2025 | Senate
    • House grants request for conf comm-reported
    • House appoints conferees-reported
  • May 20, 2025 | House
    • House grants request for conference committee
    • House appoints conferees
  • May 15, 2025 | House
    • Senate refuses to concur-reported
    • Senate requests conference committee-reported
    • Senate appoints conferees-reported
  • May 15, 2025 | Senate
    • House amendment(s) laid before the Senate
    • Read
    • Senate refuses to concur
    • Senate requests conference committee
    • Senate appoints conferees
  • May 14, 2025 | Senate
    • House passage as amended reported
  • May 13, 2025 | House
    • Read 3rd time
    • Passed
    • Record vote RV#2324
    • Statement(s) of vote recorded in Journal
  • May 12, 2025 | House
    • Comte report filed with Committee Coordinator
    • Committee report distributed
    • Committee report sent to Calendars
    • Laid out in lieu of companion HB 3717
    • Read 2nd time
    • Amended 1-Harris
    • Passed to 3rd reading as amended
    • Record vote RV#2178
  • May 08, 2025 | House
    • Considered in formal meeting
    • Committee substitute considered in committee
    • Reported favorably as substituted
  • May 02, 2025 | House
    • Read first time
    • Referred to Public Health
  • May 01, 2025 | House
    • Received from the Senate
  • Apr 30, 2025 | Senate
    • Rules suspended-Regular order of business
    • Record vote
    • Read 2nd time & passed to engrossment
    • Record vote
    • Three day rule suspended
    • Record vote
    • Read 3rd time
    • Passed
    • Record vote
    • Reported engrossed
  • Apr 29, 2025 | Senate
    • Co-author authorized
    • Placed on intent calendar
  • Apr 28, 2025 | Senate
    • Reported favorably w/o amendments
    • Committee report printed and distributed
  • Apr 24, 2025 | Senate
    • Considered in public hearing
    • Vote taken in committee
  • Apr 23, 2025 | Senate
    • Scheduled for public hearing on . . . 04/23/2025
    • Considered in public hearing
    • Testimony taken in committee
    • Left pending in committee
  • Mar 25, 2025 | Senate
    • Read first time
    • Referred to Health & Human Services
  • Mar 11, 2025 | Senate
    • Received by the Secretary of the Senate
    • Filed